345 related articles for article (PubMed ID: 12192680)
1. Registration and reregistration application fees. Final rule; remanded for further notice and comment.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 1996 Dec; 61(251):68624-6. PubMed ID: 12192680
[TBL] [Abstract][Full Text] [Related]
2. Registration and reregistration application fees. Confirmation of final rule, remanded for further notice and comment, and response to comments.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2002 Aug; 67(154):51987-52007. PubMed ID: 12194173
[TBL] [Abstract][Full Text] [Related]
3. Amendment of the fee exemption for federal, state and local government employees--DEA, Justice. Final rule.
Fed Regist; 1994 Feb; 59(37):8859. PubMed ID: 10133414
[TBL] [Abstract][Full Text] [Related]
4. Medicare program; invalidation of the wage index in the schedule of limits on Hospital per diem inpatient general routine operating costs for cost reporting periods beginning on or after July 1, 1981 and ending with cost reporting periods beginning on or before September 30, 1982--HCFA. Notice.
Fed Regist; 1983 Sep; 48(172):39998-9. PubMed ID: 10299196
[TBL] [Abstract][Full Text] [Related]
5. Controlled substances and List I chemical registration and reregistration fees. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2012 Mar; 77(51):15234-50. PubMed ID: 22420065
[TBL] [Abstract][Full Text] [Related]
6. Medicare program; revision of explanation of Medicare benefit notice and review procedures for beneficiaries; supplementary medical insurance (Part B); court order--HCFA. Notice with comment period.
Fed Regist; 1985 Dec; 50(233):49770-5. PubMed ID: 10300502
[TBL] [Abstract][Full Text] [Related]
7. Medicare program; reissuance of the wage index in the 1981 schedule of limits on hospital per diem inpatient general routine operating costs--HCFA. Proposed notice.
Fed Regist; 1984 Feb; 49(34):6175-80. PubMed ID: 10299395
[TBL] [Abstract][Full Text] [Related]
8. Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2002 Oct; 67(194):62354-70. PubMed ID: 12369590
[TBL] [Abstract][Full Text] [Related]
9. CLIA program; fee schedule revision--HCFA. General notice with comment period.
Fed Regist; 1997 Aug; 62(168):45815-21. PubMed ID: 10169844
[TBL] [Abstract][Full Text] [Related]
10. Clinton and appeals court signal death knell for Title X gag rule.
Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):1-2. PubMed ID: 12344619
[TBL] [Abstract][Full Text] [Related]
11. Establishment of revisit user fee program for Medicare survey and certification activities. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2007 Sep; 72(181):53627-49. PubMed ID: 17886406
[TBL] [Abstract][Full Text] [Related]
12. Medicare program; court ordered regulations regarding prospective payment amounts and administrative review will not become effective--HCFA. Notice that regulations will not take effect; removal of regulations.
Fed Regist; 1985 Jul; 50(147):30944. PubMed ID: 10300220
[TBL] [Abstract][Full Text] [Related]
13. The regulatory process: impacting the NP's role.
Wysocki S
Nurse Pract Forum; 1992 Jun; 3(2):56-7. PubMed ID: 1392671
[TBL] [Abstract][Full Text] [Related]
14. Information on foreign chain of distribution for ephedrine, pseudoephedrine, and phenylpropanolamine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2010 Mar; 75(43):10168-72. PubMed ID: 20383917
[TBL] [Abstract][Full Text] [Related]
15. Listed chemicals; establishment of non-regulated transactions in anhydrous hydrogen chloride. Final rule confirmation.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2001 Aug; 66(159):42944-6. PubMed ID: 11757558
[TBL] [Abstract][Full Text] [Related]
16. Control of red phosphorus, white phosphorus and hypophosphorous acid (and its salts) as list I chemicals; exclusions and waivers. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2003 Jun; 68(121):37411-4. PubMed ID: 12836650
[TBL] [Abstract][Full Text] [Related]
17. Regulations implementing the Federal Coal Mine Health and Safety Act of 1969, as amended. Employment Standards Administration, Labor. Final rule.
Fed Regist; 2000 Dec; 65(245):79920-80107. PubMed ID: 11503734
[TBL] [Abstract][Full Text] [Related]
18. Changes to patient limitation for dispensing or prescribing approved narcotic controlled substances for maintenance or detoxification treatment by qualified individual practitioners. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2008 May; 73(100):29685-8. PubMed ID: 18605404
[TBL] [Abstract][Full Text] [Related]
19. Removal of thresholds for the List I chemicals pseudoephedrine and phenylpropanolamine. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2010 Jul; 75(129):38915-22. PubMed ID: 20608288
[TBL] [Abstract][Full Text] [Related]
20. Exemption of chemical mixtures. Final rule.
Drug Enforcement Administration (DEA), U.S. Department of Justice
Fed Regist; 2007 Mar; 72(47):10925-8. PubMed ID: 17450656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
